[The influence of oral contraceptives on lipoprotein status (author's transl)].
Sera from 500 female blood donors, aged 18-40 years, were examined by quantitative lipoprotein electrophoresis. 218 women had been taking oral contraceptives for more than 3 months; the remaining 282 not on contraceptives acted as controls. The two groups were similar as to age distribution, weight and smoking habits. There were five sub-groups according to the composition of the contraceptives. It was found that all contraceptives had a favourable influence on the atherogenic beta-lipoprotein fraction. The pure progestogen preparations were less advantageous because they in particular reduced the concentration of potentially anti-atherogenic alpha-lipoproteins.
D000293:Adolescent; D000328:Adult; D001782:Blood Donors; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003534:Cyproterone / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008656:Mestranol / Q000494:pharmacology; D009765:Obesity / Q000150:complications; D045167:Progesterone Congeners / Q000494:pharmacology; D012907:Smoking
D003276:Contraceptives, Oral; D004967:Estrogens; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; D008656:Mestranol; D003534:Cyproterone
Lipoproteinstatus unter oralen Kontrazeptiva.